Medical Imaging Reagents Market Overview:
Global Medical Imaging Reagents Market was valued at $10,772 million in 2016, and is estimated to reach $18,587 million by 2023, registering a CAGR of 8.0% from 2017 to 2023. Medical imaging reagents are chemicals used to visualize organs or structures, thus assisting physicians to better diagnose and detect diseases. Hence, these compounds are widely applicable in imaging and detection technologies used in healthcare and medical industry and various life science-related fields such as medicine, biotechnology, and pharmaceutical research. The commonly used imaging technologies, such as X-ray, computed tomography, and magnetic resonance imaging, analyze the anatomy and morphology of a human body; however, these techniques cannot detect any changes at the molecular level.
Global Medical Imaging Reagents Market Segmentation
The global medical imaging reagents market is segmented based on class, technology, application, and geography. Based on class, it is categorized into contrast reagents, optical reagents, and nuclear reagents. Based on technology, it is classified into nanoparticles, fluorescent dyes & probes, radiopharmaceuticals, fluorescent proteins, and quantum dots. Based on application, it is divided into diagnostics, drug discovery & development, and R&D. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Drivers, Restraints, and Opportunities
The impact of the driving factors is expected to overcome the effect of restraints. Moreover, the technological advancements leading to higher adoption rate, development of personalized therapy, and untapped markets in developing economies are expected to provide new opportunities for the market growth in the near future.
Drivers and restraints
Global Medical Imaging Reagents Market: Key Geographical Segment
North America accounted for the largest market share in the medical imaging reagents market in 2016, and is expected to retain its dominance throughout the forecast period.
Global Medical Imaging Reagents Market, by Region, 2016 (%)
The key players operating in the global medical imaging reagents market include Bracco Imaging SpA, Bayer Healthcare AG, Lantheus Medical Imaging, Inc., GE Healthcare, Siemens Healthcare, Covalon Technologies Ltd., Thermo Fisher Scientific, Inc., Merck, Philips Healthcare, and Shimadzu Corporation.
The other significant players in the value chain include Guerbet Group, Daiichi Sankyo, nanoPET Pharma GmbH, Subhra Pharma Private Limited, and CMC Contrast AB.
- This report provides a detailed quantitative analysis of the current market trends of the global medical imaging reagents market from 2016 to 2023 to identify the prevailing opportunities.
- Market estimations are based on comprehensive analysis of the key developments in the industry.
- In-depth analysis based on geography assists in understanding the regional market to facilitate strategic business planning.
- The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.
Medical Imaging Reagents Market Key Segments:
- Contrast Reagents
- Optical Reagents
- Nuclear Reagents
- Fluorescent Dyes & Probes
- Fluorescent Proteins
- Quantum Dots
- Drug Discovery & Development
- North America
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- Republic of South Africa
- Saudi Arabia
- Rest of LAMEA